These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8704189)

  • 41. Expression of the multidrug transporter P-glycoprotein is highly correlated with clinical outcome in childhood acute lymphoblastic leukemia: results of a long-term prospective study.
    Dhooge C; De Moerloose B; Laureys G; Ferster A; De Bacquer D; Philippe J; Leroy J; Benoit Y
    Leuk Lymphoma; 2002 Feb; 43(2):309-14. PubMed ID: 11999562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia.
    Swerts K; de Moerloose B; Dhooge C; Noens L; Laureys G; Benoit Y; Philippé J
    Leuk Lymphoma; 2004 Nov; 45(11):2221-8. PubMed ID: 15512810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of MDR-1/P-glycoprotein in childhood acute megakaryoblastic leukemia cells.
    Ota S; Sato T; Kakuda H; Hirano K; Okimoto Y; Mori T; Nakazawa S; Kojima S; Matsuyama T; Tsuruo T
    Leuk Lymphoma; 1995 Nov; 19(5-6):431-6. PubMed ID: 8590843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of breast cancer resistance protein in acute lymphoblastic leukemia.
    Plasschaert SL; van der Kolk DM; de Bont ES; Kamps WA; Morisaki K; Bates SE; Scheffer GL; Scheper RJ; Vellenga E; de Vries EG
    Clin Cancer Res; 2003 Nov; 9(14):5171-7. PubMed ID: 14613996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Establishment and evaluation of MRK16-magnetic cell sorting assays for detecting low expression of multidrug resistance P-glycoprotein using human leukemia cell lines and peripheral blood cells from healthy donors.
    Okochi E; Iwahashi T; Ariyoshi K; Watabe H; Tsuruo T; Ono K
    J Immunol Methods; 1995 Nov; 187(1):127-37. PubMed ID: 7490449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MDR1/P-GP expression as a prognostic factor in acute leukemias.
    Marie JP; Legrand O
    Adv Exp Med Biol; 1999; 457():1-9. PubMed ID: 10500774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines.
    Batova A; Shao LE; Diccianni MB; Yu AL; Tanaka T; Rephaeli A; Nudelman A; Yu J
    Blood; 2002 Nov; 100(9):3319-24. PubMed ID: 12384433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nuclear DNA content and chromatin texture in multidrug-resistant human leukemic cell lines.
    Dufer J; Millot-Broglio C; Oum'Hamed Z; Liautaud-Roger F; Joly P; Desplaces A; Jardillier JC
    Int J Cancer; 1995 Jan; 60(1):108-14. PubMed ID: 7814142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia.
    Hu XF; Slater A; Kantharidis P; Rischin D; Juneja S; Rossi R; Lee G; Parkin JD; Zalcberg JR
    Blood; 1999 Jun; 93(12):4086-95. PubMed ID: 10361105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry.
    Guerci A; Merlin JL; Missoum N; Feldmann L; Marchal S; Witz F; Rose C; Guerci O
    Blood; 1995 Apr; 85(8):2147-53. PubMed ID: 7536492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by AV200, a new ardeemin derivative.
    Méndez-Vidal C; Quesada AR
    Cancer Lett; 1998 Oct; 132(1-2):45-50. PubMed ID: 10397452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of the MDR1 and MDR3 gene products in acute and chronic leukemias.
    Arai Y; Masuda M; Sugawara I; Arai T; Motoji T; Tsuruo T; Oshimi K; Mizoguchi H
    Leuk Res; 1997 Apr; 21(4):313-9. PubMed ID: 9150348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
    Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
    J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evaluation of the P-gp pump function on leukemic cell membrane and proper application of its reversal agents with Calcein-AM and flow cytometry].
    Lan ZJ; Tang YM; Shen HQ; Qian BQ; Ning BT; Chen YH
    Zhonghua Er Ke Za Zhi; 2007 May; 45(5):334-8. PubMed ID: 17697617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of multidrug resistance in multiple myeloma.
    Sonneveld P
    Baillieres Clin Haematol; 1995 Dec; 8(4):831-44. PubMed ID: 8845575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of P-glycoprotein activity in human leukemic cells by mifepristone.
    Fardel O; Courtois A; Drenou B; Lamy T; Lecureur V; le Prisé PY; Fauchet R
    Anticancer Drugs; 1996 Aug; 7(6):671-7. PubMed ID: 8913436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines.
    Bailly JD; Muller C; Jaffrézou JP; Demur C; Gassar G; Bordier C; Laurent G
    Leukemia; 1995 May; 9(5):799-807. PubMed ID: 7769842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inheritance of chromosome 7 is associated with a drug-resistant phenotype in somatic cell hybrids.
    de Silva M; Kantharidis P; Wall DM; Campbell L; Vrazas V; Nadalin G; Kaczmarczyk SJ; Hu XF; Parkin JD; Zalcberg JR
    Br J Cancer; 1996 Jan; 73(2):169-74. PubMed ID: 8546902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Augmented expression of P-gp/multi-drug resistance gene by all-trans retinoic acid in monocytic leukemic cells.
    Tokura Y; Shikami M; Miwa H; Watarai M; Sugamura K; Wakabayashi M; Satoh A; Imamura A; Mihara H; Katoh Y; Kita K; Nitta M
    Leuk Res; 2002 Jan; 26(1):29-36. PubMed ID: 11734301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.
    Hongo T; Yajima S; Sakurai M; Horikoshi Y; Hanada R
    Blood; 1997 Apr; 89(8):2959-65. PubMed ID: 9108416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.